share_log

Cadrenal Therapeutics FY 2024 GAAP EPS $(8.73) Misses $(7.59) Estimate

Benzinga ·  Mar 13 20:21

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(8.73) per share which missed the analyst consensus estimate of $(7.59) by 15.02 percent.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 229

Recommended

Write a comment